Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis

European Respiratory Journal

Volumn 11, Issue 1, 1998, Pages 104-111

  Ashitani, J ^a   Mukae, H ^a   Nakazato, M ^a   Ihi, T ^a   Mashimoto, H ^a   Kadota, J ^b   Kohno, S ^b   Matsukura, S ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bronchoalveolar lavage fluid; Defensins; Diffuse panbronchiolitis; Interleukin 8

Indexed keywords

DEFENSIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; MACROLIDE; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; ARTICLE; BLOOD LEVEL; BRONCHIOLITIS; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; LUNG FIBROSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NORMAL HUMAN; OPEN LUNG BIOPSY; PRIORITY JOURNAL;

ADULT; ANTI-INFECTIVE AGENTS; BLOOD PROTEINS; BRONCHIOLITIS; BRONCHOALVEOLAR LAVAGE FLUID; DEFENSINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MACROLIDES; MALE; MIDDLE AGED; NEUTROPHILS; OSMOLAR CONCENTRATION; PULMONARY FIBROSIS; RADIOIMMUNOASSAY; REFERENCE VALUES; TETRADECANOYLPHORBOL ACETATE; TISSUE DISTRIBUTION;

EID: 0031889912     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11010104     Document Type: Article

References (38)

1. Leffell MS, Spitznagel JK. Intracellular and extracellular degranulation of human polymorphonuclear azurophil and specific granules induced by immune complexes. Infect Immun 1974; 10: 1241-1249.
2. Ganz T, Selsted ME, Szklarek D, et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76: 1427-1435.
3. Selsted ME, Beown DM, De Lange RJ, Harwig SSL, Lehrer RI. Pulmonary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem 1985; 260: 4579-4584.
4. Eisenhauer PB, Harwig SSL, Szklarel D, Ganz T, Selsted ME, Lehrer RI. Purification and antimicrobial properties of three defensins from rat neutrophils. Infect Immun 1989; 57: 2021-2027.
5. Yamashita T, Saito K. Purification, primary structure, and biological activity of guinea pig neutrophil cationic peptides. Infect Immun 1989; 57: 2405-2409.
6. Wlide CG, Griffith JE, Marra MN, Suable JL, Scott RW. Purification and characterization of human neutrophil peptide 4. a novel member of the defensin family. J Biol Chem 1989; 264: 11200-11203.
7. Jones DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992; 267: 23216-23225.
8. Jones DE, Bevins CL. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett 1993; 315: 187-192.
9. Lichtenstein A, Ganz T, Selsted M, Lehrer RI. In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood 1986; 68: 1407-1410.
10. Lichtenstein AK, Ganz T, Nguyen T-M, Selsted ME, Lehrer RI. Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. J Immunol 1988; 140: 2686-2694.
11. Okrent DG, Lichtenstein AK, Ganz T. Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. Am Rev Respir Dis 1990; 141: 179-185.
12. Lee CT, Fein AM, Lippmann M, Holtzman H, Kimbel P, Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 1981; 304: 192-196.
13. Janoff A. Elastase and emphysema. Current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 1985; 132: 417-433.
14. Homma H, Yammaka A, Tanimoto S, et al. Diffuse panbronchiolitis: a disease of the transitional zone of the lung. Chest 1983; 83: 63-69.
15. Ichikawa Y, Ninomiya H, Koga H, et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 1992; 146: 196-203.
16. Kadota J, Sakito O, Kohno S, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 147: 153-159.
17. Mukae H, Hirota M, Kohno S, et al. Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 148: 744-751.
18. Oishi K, Sonoda F, Kobayashi S, et al. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect Immun 1994; 62: 4145-4152.
19. Shiomi K, Nakazato M, Ihi T, Kangawa K, Matsuo H, Matsukura S. Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection. Biochem Biophys Res Commun 1993; 195: 1336-1344.
20. Lynch JP III, Standiford TJ, Rolfe MW, Kunkel SL, Stricter RM. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev Respir Dis 1992; 145: 1433-1439.
21. Kudoh S. The diagnostic criteria for diffuse panbroncheolitis. Ministry of Health and Welfare in Japan, 1995.
22. Kudoh S, Uetake T, Hagiwara K, et al. Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 1987; 25: 632-642.
23. Sakito O, Kadota J, Kohno S, Abe K, Shirai R, Hara K. Interleukin 1β, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 1996; 63: 42-48.
24. Mikasa K, Sawaki M, Kita E, et al. Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: effectiveness of clarithromycin in EM ineffective cases - the fourth report. J Jpn Assoc Infect Dis 1992; 66: 1097-1104.
25. Mukae H, Kadota J, Kohno S, et al. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med 1995; 152: 613-618.
26. Nakazato M, Shiomi K, Date Y, et al. Isolation and sequence determination of 6-and 8-kDa precursors of human neutrophil peptides from bone marrow, plasma and peripheral blood neutrophils. Biochem Biophys Res Commun 1995; 211: 1053-1062.
27. Date Y, Nakazato M, Shiomi K. et al. Localization of human neutrophil peptide (HNP) and its messenger RNA in neutrophil series. Ann Hematol 1994; 69: 73-77.
28. Panyutich AV, Panyutich EA, Krapivin VA. Baturevich EA, Ganz T. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med 1993; 122: 202-207.
29. Kagan BL, Selsted ME, Ganz T, Lehrer RI. Antimicrobial defensin peptides from voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci USA 1990; 87: 210-214.
30. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049.
31. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): The major neutrophil chemotactic factor in the lung. Exp Lung Res 1991; 17: 17-23.
32. Djeu JY, Matsushima K, Oppenheim JJ, Shiotsuki K, Blanchard DK. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J Immunol 1990; 144: 2205-2210.
33. Ganz T. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun 1987; 55: 568-571.
34. Nelson S, Summer WR, Terry PB, Warr GA, Jakab GJ. Erythromycin-induced suppression of pulmonary antibacterial defenses: a potential mechanism of superinfection in the lung. Am Rev Respir Dis 1987; 136: 1207-1212.
35. Tamaoki J, Isano K, Sasaki N, Kanemura T, Konno K. Erythromycin inhibits Cl serection across canine tracheal epithelial cells. Eur Respir J 1992; 5: 234-238.
36. Yamamoto M. Annual report of diffuse disseminated lung disease. Ministry of Health and Welfare in Japan. 1991.
37. Khair OA, Devalia JL, Abdelaziz MM, Sapsford RJ, Davies RJ. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. Eur Respir J 1995; 8: 1451-1457.
38. Fujii T, Kadota J, Morikawa T, et al. Inhibitory effect of erythromycin on interleukin 8 production by 1α, 25-dihydroxyvitamin D3-stimulated THP-1 cells. Antimicrob Agents Chemother 1996; 40: 1548-1551.